Temecula, Calif., March 8, 2023 (GLOBE NEWSWIRE) — FFF Enterprises Inc., the nation’s most trusted specialty drug distributor, announced today that it has partnered with Amivas (US), LLC to bring the FDA-approved stock artesunate for injection. the life-saving malaria treatment for severe malaria.
FFF Enterprises, along with its subsidiary RightNow Inventory™ (RNI), will provide uninterrupted access to patients through its standard distribution model along with RNIs RightNow Flex™ Device, an easy-to-use, space-saving inventory management solution that leverages advanced cloud-based technology to automatically monitor inventory levels and record and report product temperature readings. The device is operated by RNI, which develops and delivers intelligent inventory technology solutions to offer on-site and on-demand management, usage and billing of medications and medical devices.
“At the beginning of our 35thth Year that puts patients first, it is an honor to work with Amivas (US), LLC to ensure continued access to Artesunate for Injection,” said Patrick M. Schmidt, Chief Executive Officer at FFF Enterprises. ” We know that accessibility saves lives, so making this time-sensitive malaria treatment available to patients in need is our top priority.”
“Time is of the essence when presenting a patient with severe malaria, and we know that FFF and RightNow Inventory™ will ensure that healthcare professionals have artesunate within reach for injection,” said David Bradshaw, Chief Executive Officer at Amivas ( US), LLC. “Amivas (US), LLC is proud of our expertise and commitment to rescuing children and adults living with severe malaria, and we’re excited to partner with FFF because they care and show.”
For more information on the symptoms and treatments of severe malaria, please click here Here. For more information on artesunate for injection, including full prescribing information, please click Here.
About FFF Enterprises Inc.
Founded in 1988, FFF Enterprises Inc. is a private…
[ad_2]
Source story
